NEWS
View news from our Featured Companies.
Modular Medical Announces Addition to the Russell Microcap® Index
SAN DIEGO, CA / June 3, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that it is...
Zoomd Technologies Reports First Quarter 2024 Financial Results
Conference call will be held on May 30, 2024 at 11AM ET VANCOUVER, BC, May 30, 2024 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech)...
Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
CUPERTINO, Calif., May 29, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Zoomd to Report First Quarter 2024 Financial Results
Conference call to be conducted on May 30, 2024, at 11 a.m. ET. VANCOUVER, BC, May 29, 2024 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech)...
Reviva Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
CUPERTINO, Calif., May 28, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Greenfire Resources Announces Participation in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Calgary, Alberta--(May 23, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the sustainable production and development of thermal energy resources from the Athabasca region of Alberta,...
S&W Seed Company to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
LONGMONT, Colo., May 23, 2024 -- S&W Seed Company (Nasdaq: SANW) announced today that Mark Herrmann, CEO, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place...
Scientific Industries to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Investor Presentation to be held at 2:45 PM Eastern TimeBOHEMIA, NY / May 23, 2024 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today it will participate in a...
Precision Optics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
GARDNER, Mass., May 23, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Dr. Joe Forkey, Chief Executive Officer, will...
SenesTech to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
PHOENIX, May 23, 2024 -- SenesTech, Inc. (NASDAQ: SNES) today announced that Joel Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham...
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
PONTE VEDRA, Fla., May 23, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths due to blood...
ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
LOS ANGELES - ChromaDex Corp. (NASDAQ: CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy-aging research, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, will be participating...
SenesTech Launches Evolve™ Fertility Control Solution for Rats on Amazon, the World’s Largest Online Retailer
PHOENIX, May 22, 2024 -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announced that it has taken a significant step forward in the distribution of EvolveTM, the Company's...
ChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award
Judges award Niagen for its "high-quality, unparalleled" healthy aging research LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, is proud to announce that its flagship ingredient,...
NeurAxis Reports First Quarter 2024 Financial Results
CARMEL, Ind., May 22, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the...
Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30
SAN DIEGO, CA / May 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, will...
Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30
SAN DIEGO, CA / May 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, will...
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
CARMEL, Ind., May 21, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will participate in a...
Reviva to Participate in the BIO International Convention
CUPERTINO, Calif., May 21, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30
SAN DIEGO, CA / May 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, will...
InfuSystem Announces $20 Million Stock Repurchase Program
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences
Encinitas, California--(May 20, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (KPRX) ("Kiora" or the "Company"), will participate in two upcoming investor conferences that will be available to investors live with the replay available on-demand. On Wednesday May...
Scientific Industries Reports Financial Results for First Quarter of Fiscal Year 2024
BIOPROCESSING REVENUES INCREASE 42% FIRST MULTI-PARAMETER SENSOR ("MPS") PRODUCTS SHIPPED IN APRILInvestor Call to be held Thursday, May 16th at 11:00 a.m. Eastern TimeBOHEMIA, NY / May 16, 2024 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool...
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
CARMEL, Ind., May 16, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced the...
Greenfire Resources Reports Voting Results from 2024 Annual Meeting of Shareholders
Calgary, Alberta--(May 15, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the sustainable production and development of thermal energy resources from the Athabasca region of Alberta,...